Showing results (121-130 of 201) with videos related to
Sort By:
Pageof 21
Human Immunology|July 1, 1992
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapyA D Hess, R J Jones, L E Morris, et al.Journal of the National Cancer Institute|December 19, 1990
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitorsE K Rowinsky, R C Donehower, J L Spivak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemiaS D Gore, L J Weng, R J Jones, et al.Leukemia & Lymphoma|October 1, 1993
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemiaA M Yeager, G B Vogelsang, R J Jones, et al.Blood|November 11, 1992
Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalationA M Yeager, J E Wagner, M L Graham, et al.Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.Blood|February 25, 1999
Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysinR A Brodsky, G L Mukhina, K L Nelson, et al.Bone Marrow Transplantation|May 1, 1990
In vitro evaluation of combination drug purging for autologous bone marrow transplantationR J Jones, C B Miller, B A Zehnbauer, et al.Biochemistry|March 16, 2005
Ligand, cofactor, and residue vibrations in the catalytic site of endothelial nitric oxide synthaseW John Ingledew, Susan M E Smith, Y T Gao, et al.Blood|November 1, 1987
Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantationR J Jones, M Zuehlsdorf, S D Rowley, et al.Pageof 21